Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of GlioblastomaAlan T. Yeo, Al Charest, Tuoye Xu et al.|Cancer Immunology Research|2023Cited by 21
Data from Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of GlioblastomaAlan T. Yeo, Al Charest, Rushil Shah et al.|Unknown|2023Cited by 3
Heterogeneity of Extracellular Vesicles and Non‐Vesicular Nanoparticles in GlioblastomaTuoye Xu, Al Charest|Journal of Extracellular Vesicles|2025Cited by 3